close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Veracyte, Inc.

< Previous 1 2 3 4 5 6 7 Next >
News headline image
New Data Show Strong Performance of Veracyte’s Afirma GSC in Real-World Clinical Practice
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Data Published in Annals of Oncology Reinforce Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier for Informing Treatment of Men Experiencing Prostate Cancer Progression
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces that New Data Show Immunoscore IC Assay May Predict Patients Likely to Benefit from Addition of Immunotherapy to Standard First-Line Therapy for Metastatic Colorectal Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data to be Shared at ASCO 2022 Underscore Clinical Utility of Decipher Prostate Genomic Classifier
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Data to be Presented at ASCO 2022 Showing Immunoscore IC Assay’s Ability to Identify Patients with NSCLC Who May Benefit from Immune Checkpoint Inhibitors
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Data Reinforcing Percepta Nasal Swab Test’s Clinical Performance and Utility in Lung Cancer Risk Assessment
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Updated AUA/ASTRO Guideline Includes Supportive Statement for Use of Genomic Tests, Including Decipher Prostate, for Men With Localized Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces First Quarter 2022 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Envisia Genomic Classifier Highlighted in Updated Clinical Practice Guideline Regarding Idiopathic Pulmonary Fibrosis Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Urologic Cancer Data To Be Presented at AUA 2022 International Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Performance Data for the Percepta Nasal Swab Test To Be Presented at ATS 2022 International Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Release First Quarter 2022 Financial Results on May 3, 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Appoints Annie McGuire as General Counsel
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Appoints Jonathan Wygant as Chief Accounting Officer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy In Men with Intermediate-Risk Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Third Quarter 2021 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.